Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Israel
  4. TEL AVIV STOCK EXCHANGE
  5. IceCure Medical Ltd
  6. Financials
    ICCM   IL0011224156

ICECURE MEDICAL LTD

(ICCM)
  Report
SummaryChartsNewsCompanyFinancials 
Valuation
Fiscal Period: December 2015 2016 2017 2018 2019 2020
Capitalization1 16,811,627,662,186,095,1
Entreprise Value (EV)1 16,811,627,662,166,969,8
P/E ratio -1,14x-0,90x-3,15x-4,28x-4,72x-5,34x
Yield ------
Capitalization / Revenue 5,65x4,82x11,5x15,4x15,0x7,24x
EV / Revenue 5,65x4,82x11,5x15,4x15,0x7,24x
EV / EBITDA -1,24x-0,99x-3,02x-5,25x-5,43x-6,90x
Price to Book ----9,46x6,45x
Nbr of stocks (in thousands) 26 46443 24343 840101 557120 149161 659
Reference price (ILS) 0,640,270,630,610,720,59
Last update 03/28/201803/28/201904/07/202003/25/202103/25/202103/25/2021
1 ILS in Million
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2015 2016 2017 2018 2019 2020
Net sales1 2,982,412,404,045,7413,1
EBITDA1 -13,5-11,7-9,15-11,8-15,9-13,8
Operating profit (EBIT)1 -13,8-11,9-9,26-11,9-16,0-14,0
Operating Margin -463%-496%-387%-296%-278%-107%
Pre-Tax Profit (EBT)1 -14,6-12,6-10,00-13,3-16,5-15,1
Net income1 -14,6-12,6-10,00-13,3-16,5-15,1
Net margin -492%-523%-417%-330%-288%-115%
EPS2 -0,56-0,30-0,20-0,14-0,15-0,11
Dividend per Share ------
Last update 03/28/201803/28/201904/07/202003/25/202103/25/202103/25/2021
1 ILS in Million
2 ILS
Balance Sheet Analysis
Fiscal Period: December 2015 2016 2017 2018 2019 2020
Net Debt ------
Net Cash position ----19,225,3
Leverage (Debt / EBITDA) ----1,21x1,84x
Free Cash Flow1 -6,95-7,65-5,07-6,70-1,15-9,16
ROE (Net Profit / Equities) -132%-109%-278%-226%-152%-127%
Shareholders' equity1 11,111,63,605,8910,911,9
ROA (Net Profit / Asset) -52,8%-46,0%-59,5%-56,3%-44,2%-29,9%
Assets1 27,727,416,823,637,450,4
Book Value Per Share ----0,080,09
Cash Flow per Share ----0,170,07
Capex1 0,020,090,030,240,350,77
Capex / Sales 0,81%3,66%1,25%5,99%6,17%5,82%
Last update 03/28/201803/28/201904/07/202003/25/202103/25/202103/25/2021
1 ILS in Million
Finances - Leverage
Financial data source
© 2021 S&P Global Market Intelligence
Key data
Capitalization (ILS)
1 053 722 040
Capitalization (USD)
320 611 586
Net sales (ILS)
13 134 000
Net sales (USD)
3 999 264
Number of employees
44
Sales / Employee (ILS)
298 500
Sales / Employee (USD)
90 892
Free-Float
48,2%
Free-Float capitalization (ILS)
507 956 541
Free-Float capitalization (USD)
154 553 807
Avg. Exchange 20 sessions (ILS)
29 550 128
Avg. Exchange 20 sessions (USD)
8 997 925
Average Daily Capital Traded
2,80%
EPS & Dividend